Key Insights

Highlights

Success Rate

97% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

2.4%

1 terminated out of 41 trials

Success Rate

96.7%

+10.2% vs benchmark

Late-Stage Pipeline

24%

10 trials in Phase 3/4

Results Transparency

24%

7 of 29 completed with results

Key Signals

7 with results97% success

Data Visualizations

Phase Distribution

16Total
Not Applicable (5)
P 2 (1)
P 3 (3)
P 4 (7)

Trial Status

Completed29
Recruiting7
Unknown2
Active Not Recruiting1
Terminated1
Not Yet Recruiting1

Trial Success Rate

96.7%

Benchmark: 86.5%

Based on 29 completed trials

Clinical Trials (41)

Showing 20 of 20 trials
NCT07563231Not Yet Recruiting

ABLUMINUS NP Polymer Free Sirolimus-Eluting Stent Registry at Geneva University Hospitals (ABLUMINUS-GVA)

NCT06308952Phase 4Recruiting

Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation

NCT06700018RecruitingPrimary

Flow Patterns and Stent Thrombosis

NCT07182799Active Not Recruiting

Starring Optical Coherence Tomography During Percutaneous Coronary Intervention Guidance

NCT06318481Phase 3CompletedPrimary

TADCLOT- a Double Blind Randomized Controlled Trial

NCT06880978Recruiting

Mini-Crush Or Controlled Balloon-Crush For True Coronary Bifurcation Lesions

NCT06667349Phase 4Completed

TISSARA Trial: Ticagrelor Intervention to Reduce Stent Thrombosis and Acute MI Risk

NCT04988685Recruiting

SIROOP Registry - a Prospective Registry Study to Evaluate the Outcomes of Coronary Artery Disease Patients Treated with SIROlimus or Paclitaxel Eluting Balloon Catheters

NCT06075602Recruiting

COMPLEX Registry - a Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting with CompLEX and Calcified Coronary Artery Disease

NCT03118895Not ApplicableCompleted

Leaders Free III: BioFreedom™ Clinical Trial

NCT04436978Phase 4Recruiting

What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?

NCT04702113Not ApplicableCompleted

Evaluating Pharmacogenomic Variants for Cardiology Therapeutics

NCT05244629Not ApplicableRecruiting

Copenhagen Mesenteric Stent Study - A Randomized Trial of Stent Versus Covered Stent Treatment for Chronic Mesenteric Ischemia

NCT04580602CompletedPrimary

Association Between Genetic Variant Scores and P2Y12 Inhibitor Effects

NCT03862352Completed

Glasgow Natural History Study Of Covered Coronary Interventions

NCT04734028Completed

PTRG-DES Consortium

NCT03312296Completed

Definite Stent Thrombosis in Comatose Out of Hospital Cardiac Arrest Survivors

NCT03209843Not ApplicableCompleted

Post-stenting Assessment of Reendothelialization With OFDI After CTO Procedure (PERFECTO)

NCT04715594UnknownPrimary

CONNECT DES Registrty

NCT02617290Phase 3Completed

Assessment of Loading With the P2Y12 Inhibitor Ticagrelor or Clopidogrel to Halt Ischemic Events in Patients Undergoing Elective Coronary Stenting

Scroll to load more

Research Network

Activity Timeline